Six “Antimicrobial Resistance (AMR) Roadmaps”, one for each of the World Health Organization regions, that define and prioritise major milestones towards mitigating AMR for the period 2024 to 2028, are published by FIP today.

The roadmaps were developed by FIP in collaboration with its regional pharmaceutical forums and, for the European Region, with FIP member organisations in Europe as there is no FIP regional pharmaceutical forum in the European region. The new roadmaps have been developed to follow roadmaps for 2020-2024. The new publication also presents various activities against AMR that have been undertaken in countries of each region.